Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹92332 Cr.
Stock P/E
85.8
P/B
8.6
Current Price
₹948.7
Book Value
₹ 110.5
Face Value
10
52W High
₹1314.3
52W Low
₹ 903.5
Dividend Yield
0.21%

Max Healthcare Inst Overview

Business

Max Healthcare Institute Ltd. is one of India's leading providers of comprehensive, integrated, and high-quality healthcare services. The company operates a chain of super-specialty hospitals primarily focused on tertiary and quaternary care in major metro cities, particularly strong in the Delhi-NCR region. Its core business model involves operating these hospitals, offering a wide spectrum of medical services including diagnostics, consultations, inpatient and outpatient care, complex surgeries, and emergency services. Max Healthcare generates revenue primarily through patient services, including fees for medical procedures, consultations, room charges, diagnostics, and pharmaceutical sales within its facilities. It serves both domestic and international patients, positioning itself as a premium healthcare provider.

Revenue Mix

Max Healthcare's primary business segment is hospital services. Revenue is largely derived from a mix of inpatient (IPD) and outpatient (OPD) services. While specific percentage breakdowns vary by reporting period, inpatient services, including surgeries, critical care, and extended hospital stays, typically constitute the significant majority of its revenue for large hospital chains. Other revenue streams include diagnostics, pharmacy sales, and medical tourism.

Industry

The Indian hospital and healthcare services industry is characterized by robust growth, driven by increasing population, rising disposable incomes, growing health insurance penetration, and a higher incidence of lifestyle diseases. It is a fragmented industry with a mix of public and private players, though consolidation is occurring in the private sector. Max Healthcare is positioned as one of the largest and most reputed private hospital chains in India, particularly prominent in North India. It is known for its super-specialty offerings, advanced medical technology, and highly skilled medical professionals, catering to a premium segment of the market and attracting significant medical tourism.

MOAT

Brand Reputation & Trust: Established brand name synonymous with quality, clinical excellence, and specialized care, particularly in North India. This builds patient trust and preference.

Scale & Network: Operates a large network of hospitals and bed capacity, especially in strategic urban centers like Delhi-NCR, which provides operational efficiencies, strong referral systems, and a wide patient reach.

Clinical Excellence & Talent Pool: Reputation for complex medical procedures, state-of-the-art infrastructure, and ability to attract and retain highly experienced doctors and specialists.

High Capital Intensity: The hospital industry requires significant capital investment for infrastructure, technology, and land, creating high barriers to entry for new competitors.

Switching Costs: For critical and chronic care, patients often develop trust and familiarity with a healthcare provider and their medical team, leading to high perceived switching costs.

Growth Drivers

Increasing Healthcare Expenditure: Rising per capita income and health consciousness are leading to higher out-of-pocket spending and greater health insurance adoption.

Demographic Shifts: India's large and aging population, coupled with a rise in lifestyle-related and chronic diseases, drives demand for specialized medical services.

Medical Tourism: India's position as an attractive destination for high-quality, cost-effective medical treatment, particularly for super-specialty procedures, benefits Max Healthcare.

Expansion & Capacity Addition: Organic growth through brownfield expansion (adding beds in existing facilities) and inorganic growth through acquisitions of new hospitals.

Technological Advancements: Adoption of advanced medical technologies and digital health solutions to improve patient outcomes and operational efficiency.

Government Focus on Healthcare: Increased government spending and initiatives to improve healthcare infrastructure and access.

Risks

Regulatory & Pricing Risks: Potential government intervention in healthcare pricing (e.g., procedure caps, drug price controls) could impact profitability.

Manpower & Talent Retention: High reliance on skilled medical professionals (doctors, nurses). Competition for talent and rising personnel costs can impact margins.

Intense Competition: Competition from other large hospital chains and regional players, potentially leading to pricing pressures.

High Capital Expenditure: Significant capital requirements for facility expansion, maintenance, and technological upgrades can strain financial resources.

Medical Malpractice & Litigation: Risks associated with medical errors, litigation, and reputational damage.

Economic Downturns: Could impact patient affordability for elective procedures and overall healthcare spending.

Infrastructure & Utilities: Reliance on consistent supply of power, water, and other utilities in a capital-intensive environment.

Management & Ownership

Max Healthcare is promoted by Radiant Life Care Private Ltd., led by Abhay Soi, who is the Chairman and Managing Director. Global private equity firm KKR also holds a significant stake in the company, reflecting institutional investor confidence and a professional approach to governance. The management team is generally perceived as experienced in the healthcare sector, with a focus on operational efficiency, quality healthcare delivery, and strategic expansion. The ownership structure includes the promoter group, KKR, other institutional investors (domestic and foreign), and public shareholders.

Outlook

Max Healthcare is well-positioned to capitalize on India's structural healthcare growth drivers, including rising incomes, increasing health awareness, and medical tourism. Its strong brand, extensive network, and focus on super-specialty care provide a durable competitive edge. Successful execution of its expansion plans, coupled with improving operational efficiencies and higher Average Revenue Per Occupied Bed (ARPOB), could drive sustained revenue and profitability growth. However, the company faces inherent risks such as potential regulatory price caps, intense competition for talent and patients, and the high capital expenditure required for continuous expansion and technological upgrades. These factors necessitate careful management of costs and strong execution to maintain its premium positioning and profitability in a dynamic market.

Max Healthcare Inst Share Price

Live · BSE / NSE · Inception: 2001
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Max Healthcare Inst Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 1335 1423 1543 1707 1868 1910 2028 2135 2068 2143
Other Income 46 44 35 41 33 47 37 33 45 48
Total Income 1381 1467 1578 1748 1902 1957 2064 2168 2113 2191
Total Expenditure 949 1040 1156 1257 1369 1398 1505 1560 1529 1536
Operating Profit 432 427 422 491 532 559 559 608 584 654
Interest 11 21 24 34 52 55 55 54 60 67
Depreciation 61 70 77 84 98 101 104 108 111 123
Exceptional Income / Expenses 0 0 0 0 -74 0 0 0 -48 0
Profit Before Tax 360 336 321 374 309 403 400 446 365 465
Provision for Tax 70 84 85 92 70 84 92 -45 64 122
Profit After Tax 289 252 236 282 239 319 308 491 301 342
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 289 252 236 282 239 319 308 491 301 342
Adjusted Earnings Per Share 3 2.6 2.4 2.9 2.5 3.3 3.2 5.1 3.1 3.5

Max Healthcare Inst Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 1134 1434 1608 1729 1691 1059 2508 3937 4563 5406 7028 8374
Other Income 27 36 42 55 67 53 135 132 152 189 164 163
Total Income 1161 1471 1651 1784 1758 1112 2643 4068 4715 5595 7192 8536
Total Expenditure 1058 1331 1468 1616 1546 970 2124 2998 3335 3925 5188 6130
Operating Profit 102 140 183 167 212 142 519 1070 1380 1670 2004 2405
Interest 61 68 100 99 101 83 179 101 84 60 165 236
Depreciation 78 91 96 94 103 46 174 221 232 245 359 446
Exceptional Income / Expenses 0 0 0 0 0 0 -234 -9 0 0 -74 -48
Profit Before Tax -37 -19 -12 -26 8 13 -69 739 1064 1365 1406 1676
Provision for Tax 0 4 -11 2 9 -0 46 134 -40 308 330 233
Profit After Tax -37 -23 -1 -29 -0 13 -115 605 1104 1058 1076 1442
Adjustments 0 0 17 8 -3 46 -23 0 0 0 0 0
Profit After Adjustments -37 -23 16 -21 -3 59 -138 605 1104 1058 1076 1442
Adjusted Earnings Per Share -0.8 -0.4 0.3 -0.4 -0.1 1.1 -1.4 6.2 11.4 10.9 11.1 14.9

Max Healthcare Inst Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 831 1145 1192 1167 963 2553 5639 6282 7410 8408 9381
Minority's Interest 0 -17 -73 -133 0 0 0 0 0 0 0
Borrowings 332 649 772 849 890 106 843 629 497 1061 2270
Other Non-Current Liabilities 7 846 875 944 361 304 1285 1520 1150 1282 1722
Total Current Liabilities 282 422 380 478 1140 1010 777 757 1046 1249 1814
Total Liabilities 1453 3045 3146 3304 3355 3974 8543 9189 10102 12000 15186
Fixed Assets 740 2273 2244 2227 2192 851 6536 7018 7039 8721 11497
Other Non-Current Assets 330 482 552 645 715 207 883 1171 1120 1573 2097
Total Current Assets 383 290 349 432 447 2915 1124 1000 1943 1706 1593
Total Assets 1453 3045 3146 3304 3355 3974 8543 9189 10102 12000 15186

Max Healthcare Inst Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 10 25 11 15 9 322 111 627 481 1374 980
Cash Flow from Operating Activities 64 723 156 82 89 77 118 741 1284 1122 1459
Cash Flow from Investing Activities -194 -1340 -104 -100 -17 -2641 -73 -764 -102 -1285 -1632
Cash Flow from Financing Activities 145 603 -48 12 -74 2353 191 -294 -289 -264 -164
Net Cash Inflow / Outflow 16 -14 4 -6 -2 -210 236 -317 893 -428 -336
Closing Cash & Cash Equivalent 25 11 15 9 8 111 627 309 1374 980 661

Max Healthcare Inst Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -0.76 -0.42 0.29 -0.39 -0.06 1.1 -1.42 6.24 11.37 10.88 11.07
CEPS(Rs) 0.85 1.29 1.75 1.22 1.91 1.09 0.62 8.52 13.76 13.4 14.76
DPS(Rs) 0 0 0 0 0 0 0 0 1 1.5 1.5
Book NAV/Share(Rs) 17.01 21.47 22.19 21.72 17.93 47.52 58.1 64.57 75.89 85.82 95.27
Core EBITDA Margin(%) 6.64 7.22 8.73 6.52 8.6 8.37 15.3 23.84 26.9 27.4 26.19
EBIT Margin(%) 2.13 3.4 5.42 4.21 6.48 9.07 4.42 21.33 25.15 26.36 22.36
Pre Tax Margin(%) -3.27 -1.32 -0.78 -1.53 0.49 1.21 -2.74 18.77 23.31 25.26 20.01
PAT Margin (%) -3.27 -1.58 -0.09 -1.66 -0.01 1.22 -4.57 15.37 24.19 19.56 15.31
Cash Profit Margin (%) 3.65 4.78 5.85 3.8 6.06 5.53 2.38 20.99 29.28 24.1 20.42
ROA(%) -2.71 -1.01 -0.05 -0.89 -0.01 0.35 -1.83 6.82 11.44 9.57 7.91
ROE(%) -5.64 -2.29 -0.12 -2.44 -0.02 0.73 -2.8 10.19 16.19 13.47 12.22
ROCE(%) 2.11 3.05 4.34 3.46 5.33 3.57 2.22 12.38 15.32 16.26 14.67
Receivable days 54.39 48.61 50.32 52.01 66.97 79.05 33.62 34.83 28.86 26.97 29.86
Inventory Days 5.43 5.31 5.26 5.42 5.86 9.1 5.87 5.34 5.5 5.27 4.83
Payable days 162.82 170.36 185.81 205.78 279.46 395.74 188.92 173.98 195.48 191.96 178.04
PER(x) 0 0 0 0 0 0 0 55.59 38.8 75.39 99.1
Price/Book(x) 0 0 0 0 0 0 3.55 5.37 5.81 9.56 11.51
Dividend Yield(%) 0 0 0 0 0 0 0 0 0.23 0.18 0.14
EV/Net Sales(x) 0.78 0.92 0.86 0.83 0.9 1.2 8.04 8.6 9.19 14.76 15.43
EV/Core EBITDA(x) 8.61 9.45 7.6 8.53 7.2 8.99 38.89 31.65 30.38 47.77 54.09
Net Sales Growth(%) 20.03 26.51 12.14 7.52 -2.2 -37.37 136.82 56.96 15.9 18.49 30.01
EBIT Growth(%) 1281.86 102.36 78.7 -16.41 50.37 -12.38 15.4 657.85 36.65 24.19 10.26
PAT Growth(%) 42.69 38.97 93.81 -1952.14 99.34 6894.74 -986.91 628.43 82.38 -4.16 1.72
EPS Growth(%) 49.91 44.07 169.34 -231.6 85.52 2060.71 -229.69 538.21 82.14 -4.25 1.7
Debt/Equity(x) 0.51 0.7 0.73 0.84 1.04 0.33 0.16 0.12 0.08 0.14 0.27
Current Ratio(x) 1.36 0.69 0.92 0.9 0.39 2.89 1.45 1.32 1.86 1.37 0.88
Quick Ratio(x) 1.29 0.63 0.86 0.84 0.37 2.86 1.38 1.24 1.79 1.3 0.82
Interest Cover(x) 0.39 0.72 0.87 0.73 1.08 1.15 0.62 8.33 13.68 23.8 9.52
Total Debt/Mcap(x) 0 0 0 0 0 0 0.05 0.02 0.01 0.01 0.02

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +30% +21% +46% +20%
Operating Profit CAGR +20% +23% +70% +35%
PAT CAGR +2% +21% +142%
Share Price CAGR -18% +21% +33%
ROE Average +12% +14% +10% +4%
ROCE Average +15% +15% +12% +8%

Max Healthcare Inst Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 23.71 %
FII 45.39 %
DII (MF + Insurance) 26.32 %
Public (retail) 76.29 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 23.7523.7523.7423.7423.7423.7423.7423.7423.7223.71
FII 60.6857.3256.9757.2956.9354.7454.7651.850.5545.39
DII 11.5814.9715.3715.1415.5517.5817.4220.0321.226.32
Public 76.2576.2576.2676.2676.2676.2676.2676.2676.2876.29
Others 0000000000
Total 100100100100100100100100100100

Max Healthcare Inst Peer Comparison

Hospital & Healthcare Services Edit Columns

Max Healthcare Inst Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Max Healthcare Inst Pros & Cons

Pros

  • Company has delivered good profit growth of 141% CAGR over last 5 years
  • Debtor days have improved from 191.96 to 178.04days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 23.71%.
  • Company has a low return on equity of 14% over the last 3 years.
  • Stock is trading at 8.6 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp